Firefly Health vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 34)
Firefly Health logo

Firefly Health

EmergingHealthTech

Virtual Primary Care

Firefly Health operates a virtual-first primary care practice with dedicated care teams, offering comprehensive primary care, mental health, and chronic disease management through a mobile app.

AI VisibilityBeta
Overall Score
D34
Category Rank
#580 of 596
AI Consensus
77%
Trend
stable
Per Platform
ChatGPT
29
Perplexity
38
Gemini
36

About

Firefly Health delivers virtual-first primary care through a model built around dedicated care teams — a physician, health coach, and care coordinator assigned to each patient — rather than the on-demand provider matching used by most telehealth platforms. Patients access their care team through the Firefly app for video visits, messaging, lab result review, specialist referrals, and care plan management, with the team maintaining longitudinal knowledge of their health history and goals.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

34
Overall Score
90
#580
Category Rank
#2
77
AI Consensus
83
stable
Trend
stable
29
ChatGPT
92
38
Perplexity
93
36
Gemini
89
31
Claude
96
31
Grok
95

Key Details

Category
Virtual Primary Care
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Firefly Health
Virtual Primary Care

Integrations

Only Moderna
Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.